NYSE$HR
Healthcare Realty Trust Inc · Q3 2021 earnings
Q3 2021 earnings · · Investor relations
Briefing
Reported strong results driven by strategic partnerships and portfolio performance.
Healthcare Trust of America reported a positive third quarter, marked by an increase in FFO per diluted share and strategic investments. The company's portfolio performance remained robust, with a leased rate increase and successful lease executions. HTA is actively engaged in a strategic review process to enhance shareholder value.
- Net income attributable to common stockholders was $0.10 per diluted share.
- FFO increased by 41.9% compared to Q3 2020, reaching $0.44 per diluted share.
- Same-Property Cash Net Operating Income (NOI) grew by 2.5% compared to Q3 2020.
- Closed on four medical office building investments totaling $135 million with 469,000 square feet of GLA at anticipated in-place year one yields of 5.7%.
Headline financials
Revenue & EPS history
Healthcare Realty · Revenue · Quarterly
$191M
Revenue by segment
Healthcare Realty · $1.43M total across 1 segment · Q3 2021
- Interest Income$1.43M—100.0%
Forward guidance
HTA updates its 2021 guidance with net income attributable to common stockholders per share between $0.44 and $0.48, Same-Property Cash NOI between 2.0% and 2.5%, FFO per share as defined by NAREIT between $1.73 and $1.77, and Normalized FFO per share between $1.75 and $1.77.
Tailwinds
- $400 - $500 million of investments at an average 5.5% to 6.0% yield
- General and administrative costs of $43 - $46 million
- Developments being substantially completed as planned
- Average fully diluted shares of between 224 and 225 million fully diluted shares of common stock outstanding, with proceeds from equity previously raised on a forward basis being utilized to fund acquisitions as they close.
- HTA expects leverage to range between 5.5x and 6.0x throughout the year.
Headwinds
- The 2021 guidance is based on a number of assumptions that are subject to change and many of which are beyond HTA’s control.
- HTA’s guidance does not contemplate impacts from gains or losses from dispositions, potential impairments, or debt extinguishment costs, if any.
- If actual results vary from these assumptions, HTA’s expectations may change.
- The lower end of the range assumes settlement of forward equity agreements without deployment of cash proceeds for investments.
- There can be no assurance that HTA will achieve these results.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2021
-0.6%
Avg return
Earnings day
+0.1%
Avg return
5 days after
-0.2%
Avg return
30 days after
45%
29 / 65 earnings
Positive
+5.8%
Q3 2022
Best reaction
-10.1%
Q4 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.9% | +8.2% | +6.6% | |
| Q4 2025 | +2.7% | +3.1% | +2.8% | |
| Q3 2025 | -0.6% | +1.0% | +2.6% | |
| Q1 2025 | -4.4% | -4.3% | -8.7% | |
| Q4 2024 | -1.3% | -1.0% | -2.2% | |
| Q3 2024 | -5.3% | -5.1% | +1.0% | |
| Q2 2024 | -0.3% | +0.8% | +1.7% | |
| Q1 2024 | +2.1% | +2.5% | +10.2% | |
| Q4 2023 | -10.1% | -8.8% | -17.8% | |
| Q3 2023 | +1.1% | -1.1% | +5.1% | |
| Q2 2023 | -6.0% | -8.5% | -15.3% | |
| Q1 2023 | -1.5% | +0.6% | -1.4% | |
| Q4 2022 | +0.7% | -4.0% | -5.9% | |
| Q3 2022 | +5.8% | +0.4% | +0.6% | |
| Q2 2022 | +3.6% | +3.9% | -4.0% | |
| Q1 2022 | -0.2% | -2.4% | -9.8% | |
| Q4 2021 | -8.8% | -4.5% | -5.2% | |
| Q3 2021 | +1.2% | +1.8% | -0.9% | |
| Q2 2021 | -2.6% | -0.5% | -2.3% | |
| Q1 2021 | +2.5% | +0.8% | -1.4% | |
| Q4 2020 | +0.4% | +0.7% | -0.3% | |
| Q3 2020 | +4.6% | +7.3% | +3.8% | |
| Q2 2020 | +1.6% | -1.6% | +2.8% | |
| Q1 2020 | +4.0% | +9.2% | +10.0% | |
| Q4 2019 | +1.2% | +1.8% | -6.3% | |
| Q3 2019 | -6.6% | -7.4% | -4.6% | |
| Q2 2019 | -1.1% | -0.6% | +2.2% | |
| Q1 2019 | -0.4% | +0.3% | +4.4% | |
| Q4 2018 | +2.0% | +2.7% | +0.4% | |
| Q3 2018 | -1.3% | +2.5% | +11.3% | |
| Q2 2018 | +2.7% | +4.1% | +4.0% | |
| Q1 2018 | +1.8% | +1.2% | +0.4% | |
| Q4 2017 | -2.1% | -0.8% | -1.5% | |
| Q3 2017 | +0.4% | +1.3% | +2.9% | |
| Q2 2017 | +0.3% | -0.3% | +0.5% | |
| Q1 2017 | -1.5% | +1.0% | +7.3% | |
| Q4 2016 | +2.7% | +2.8% | +3.4% | |
| Q3 2016 | -3.6% | -1.4% | -5.5% | |
| Q2 2016 | +0.3% | -0.6% | -0.5% | |
| Q1 2016 | +0.6% | — | — | |
| Q4 2015 | -1.4% | — | — | |
| Q3 2015 | -0.7% | — | — | |
| Q2 2015 | -0.2% | — | — | |
| Q1 2015 | +0.0% | — | — | |
| Q4 2014 | +2.0% | — | — | |
| Q3 2014 | -0.3% | — | — | |
| Q2 2014 | -1.2% | — | — | |
| Q1 2014 | -1.6% | — | — | |
| Q4 2013 | +1.1% | — | — | |
| Q3 2013 | -2.5% | — | — | |
| Q2 2013 | -3.9% | — | — | |
| Q1 2013 | +0.7% | — | — | |
| Q4 2012 | -1.8% | — | — | |
| Q3 2012 | -2.5% | — | — | |
| Q2 2012 | -0.9% | — | — | |
| Q1 2012 | -4.0% | — | — | |
| Q1 2011 | -4.0% | — | — | |
| Q4 2009 | +1.1% | — | — | |
| Q4 2011 | +1.1% | — | — | |
| Q3 2011 | -2.9% | — | — | |
| Q4 2010 | +3.4% | — | — | |
| Q2 2011 | +3.4% | — | — | |
| Q3 2010 | -6.4% | — | — | |
| Q2 2010 | -0.9% | — | — | |
| Q1 2010 | -6.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro